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Mutations in C19orf12 have been identified in patients affected by Neurodegeneration
with Brain Iron Accumulation (NBIA), a clinical entity characterized by iron accumulation
in the basal ganglia. By using western blot analysis with specific antibody and confocal
studies, we showed that wild-type C19orf12 protein was not exclusively present in
mitochondria, but also in the Endoplasmic Reticulum (ER) and MAM (Mitochondria
AssociatedMembrane), while mutant C19orf12 variants presented a different localization.
Moreover, after induction of oxidative stress, a GFP-tagged C19orf12 wild-type protein
was able to relocate to the cytosol. On the contrary, mutant isoforms were not able
to respond to oxidative stress. High mitochondrial calcium concentration and increased
H2O2 induced apoptosis were found in fibroblasts derived from one patient as compared
to controls. C19orf12 protein is a 17 kDa mitochondrial membrane-associated protein
whose function is still unknown. Our in silico investigation suggests that, the glycine
zipper motifs of C19orf12 form helical regions spanning the membrane. The N- and
C-terminal regions with respect to the transmembrane portion, on the contrary, are
predicted to rearrange in a structural domain, which is homologs to the N-terminal
regulatory domain of the magnesium transporter MgtE, suggesting that C19orf12 may
act as a regulatory protein for human MgtE transporters. The mutations here described
affect respectively one glycine residue of the glycine zipper motifs, which are involved in
dimerization of transmembrane helices and predicted to impair the correct localization
of the protein into the membranes, and one residue present in the regulatory domain,
which is important for protein-protein interaction.
Keywords: mitochondria, oxidative stress, neurodegeneration with brain iron accumulation, endoplasmic
reticulum-mitochondria associated membranes (ER-MAM), molecular modeling, simulation
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Introduction
The acronymNBIA identifies a group of clinically and genetically
heterogeneous rare pathological conditions, characterized by
progressive extra-pyramidal disorders and by evidence of focal
iron accumulation in the brain, especially in basal ganglia, and
globus pallidus, observed in MRI studies.
Recently, thanks to the identification of new disease genes in
these years there has been an increasing knowledge about NBIA,
but pathomechanisms underlining these disorders are still not
completely clear. Up to now 10 genes have been associated with
specific forms of NBIA (Kalman et al., 2012). Only two forms
inherited as autosomal dominant and recessive traits respectively
are caused by mutations in genes coding for proteins directly
involved in iron metabolism: neuroferritinopathy due to ferritin
light chain gene (FTL) (MIM#606159) mutation (Chinnery
et al., 2007) and aceruloplasminemia linked to mutations in
the ceruloplasmin gene (CP) (MIM#117700) (McNeill et al.,
2008).
The other forms with autosomal recessive or X-linked
transmission are due to mutations in genes (Rouault, 2013)
coding for proteins with a variety of functions including:
Coenzyme A biosynthesis, fatty acid metabolism, autophagy, and
still unknown roles.
This is the case for the C19orf12 gene, coding for
a mitochondrial membrane protein, which mutations are
responsible for a form of disease called MPAN for Mitochondrial
membrane Protein Associated Neurodegeneration (Hartig et al.,
2012). Mean age at onset is 9 years and the clinical phenotype
is characterized by: progressive spastic para and tetraparesis,
generalized dystonia, optic atrophy, motor axonal neuropathy,
and psychiatric signs. T2-weighted MRI reveals hypointensities
in the globus pallidus and substantia nigra. Mutations of
C19orf12 were also found in a patient with Parkinson disease
(Hartig et al., 2012) and post mortem examination of the brain of
one MPAN patient revealed Lewy bodies, tangles, spheroids, and
tau pathology, indicating a possible overlap between NBIA and
more common neurodegenerative diseases. There is no direct
link between C19orf12 mutations and the clinical phenotype
of the patients, although preliminary evidence suggests for this
gene a role in lipid homeostasis (Hartig et al., 2012). Recently,
a Drosophila model (Iuso et al., 2014) has been generated,
which shows neurological problems that can resemble the clinical
features present in patients.
To gain insight into the functional properties of wild-type
and mutant encoded proteins, corresponding to homozygous
mutations Q96P and G58S, identified in two affected patients
(Panteghini et al., 2012), we performed immunolocalization
and confocal assays under normal and stress conditions. Since
no structural information are available on C19orf12, we also
exploited molecular modeling techniques and we predicted
that the protein has transmembrane helices with glycine-zipper
motifs and a soluble domain that is homologous to the N-
regulatory domain of bacterial MgtE transporter. The mutations
identified in the patients are predicted to structurally destabilize
both the glycines of the transmembrane zipper motif and the
soluble domain, where the Q96P especially may impair the helical
structure of the fourth α-helix of the homology model, which
correspond to helix α6 of the bacterial domain.
Methods
Cloning Procedures and Plasmid Vectors
Mutagenesis
Human C19orf12 was cloned in the pCMV-AC-GFP (OriGene)
vector containing a C-terminal green fluorescent protein. cDNA
was amplified by PCR from pCMV-AC-GFP construct with
primers carrying c-myc tag (underlined sequence) described
below, and cloning in the pcDNA3.1(-), in order to obtain a
recombinant protein with a smaller tag than the GFP-one. The
cDNA was PCR amplified with these primers:
Fw: 5′-TCTGCCGCCGCGATCGCCATGGAGA-3′
Rv: 5′-CGGTTATCACAAGTCCTCTTCAGAAATGAGCTT
TTGCTCGTCATCATACTGGATCTCGG-3′
The mutant versions corresponding to the G58S and Q96P
were obtained by site directed mutagenesis (QuikChange II
Site-Directed Mutagenesis Kit Stratagene). The corresponding
modified primers used to generate mutated allele are as follows:
G58S Fw: 5′-GGGGGTTTGGTGGGCAGCCCACCGGGAC
TCGCC-3′
G58S Rv: 5′-GGCGAGTCCCGGTGGGCTGCCCACCAA
ACCCCC-3′
Q96P Fw: 5′-CCCCCTGCCGAGCCACAGAGGCTCTTTA
ACGAAGCC-3′
Q96P Rv: 5′-GGCTTCGTTAAAGAGCCTCTGTGGCTCG
GCAGGGGG-3′
We use also a vector containing the mkate2 red fluorescent
protein (Envrogen) additionally to the GFP in order to perform
live imaging experiments. Cloning Procedures and Plasmid
Vectors pmKate2-N-c19orf12 was obtained as follows. The two
original plasmids pCMV6-AC-GFP and pmKate2-N contained
appropriate restriction sites to allow cloning in the EcoRI-XhoI
for the first one and EcoRI-SalI for the second one. XhoI and
SalI produce compatible cohesive ends and produce recleavable
ligation products. All cloned fragments were sequenced to
check the absence of mutations. Restriction-enzyme digestions,
Escherichia coli transformation, and plasmid extractions were
performed with standard methods.
Cell Culture, Transient Transfection, Stable
Transduction
HeLa and HEK-293 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) (Euroclone), supplemented with 10%
fetal bovine serum (FBS). Cells were seeded 36 h before
transfection onto round glass coverslips for imaging or 13-mm
diameter petri dishes for aequorin experiments, or in 10-cm
petri dishes for immunoblot and fractionation experiments. Cells
were allowed to grow to 50% confluence, then transfected with a
standard calcium phosphate procedure (Sambrook and Russell,
2006) and used in the experiments 36-h post-transfection.
Quantitative Colocalization Analysis
HeLa cells were co-transfected with wild-type or mutant
C19orf12 fused in frame with mkate2 fluorescent marker
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and with the ER marker GFP–Sec61-β. Thirty six hour after
transfection, cells were stained with the mitochondrial dye
Mitotracker Deep Red 200 nM in PBS for 10min at 37◦.
After washing cells were imaged with and LSM510 confocal
microscope equipped with a Plan-Apochromat 63X/1.4 n.a. Oil
objective and acquired with a pixel size of 142 nm.
Live Imaging
HeLa cells were co-transfected with GFP-tagged C19orf12
wild-type or mutant chimeras and the mitochondrial marker
mtDsRed using calcium phosphate method. Thirty six hour after
transfection, time-lapse recording were performed with a Nikon
Swept Field Confocal equipped with CFI Plan Apo VC60XH
objective (numerical aperture, 1.4) (Nikon Instruments, Melville,
NY, USA) and an Andor DU885 electron multiplying charge-
coupled device (EM-CCD) camera (Andor Technology Ltd,
Belfast, Northern Ireland), the overall image sampling was below
the resolution limit (X and Y pixel size: 133 nm). Coverslips were
placed in an incubated chamber with controlled temperature,
CO2 and humidity; images were then acquired with a differential
frequency during the experiment: cells were placed in 1mMCa2+
KRB and basal fluorescence images were acquired for 5min; then
cells were stimulated with H2O2 (500µMfinal), and fluorescence
images were acquired for 1 h and 30min.
Image Analysis
Acquired images were then analyzed by using open source
software Fiji. Images were corrected for spectral bleedthrough
using the Spectral Unmixing plugin (available at http://rsbweb.
nih.gov/ij/plugins/spectral-unmixing.html). Then, single cells
were analyzed, and, for each of those, the Manders’ overlap
coefficient was obtained using the JACOP plugin (available at
http://rsb.info.nih.gov/ij/plugins/track/jacop.html).
Mitochondria Preparation and Fractionation
Isolated mitochondria from cultured cells were obtained
according to the protocol described (Fernandez-Vizarra et al.,
2010).
Isolated mitochondria were resuspended in 100ml of
potassium phosphate buffer [(PP) buffer, 20mM, pH 7.8,
KCl 150mM] and sonicated 10 s for three times at 10Amp.
The suspension was centrifuged at 164000 g for 30min at
48C. Supernatant (mitochondrial matrix and inter-membrane
space) was collected, and pellet (mitochondrial membranes) was
resuspended in 100ml of PP buffer.
MAM and ER Fraction Preparation
Hek cells (Wieckowski et al., 2009) were harvested, washed in
phosphate-buffered saline medium, pelleted by centrifugation
at 500 × g for 5min, resuspended in homogenization buffer
(0.25M sucrose and 10mM Hepes pH 7.4) and gently disrupted
by dounce homogenization. The homogenate was centrifuged
twice at 600 × g for 5min to remove cellular debris and
nuclei, and the supernatant was centrifuged at 10.300 × g for
10min to pellet crude mitochondria. The resultant supernatant
was centrifuged at 100.000 × g for 1 h in a Beckman 70 Ti
rotor at 40C to pellet microsomes, which were resuspended in
homogenization buffer. Themitochondrial pellet, resuspended in
isolation medium (250mM mannitol, 5mM Hepes (pH7.4), and
0.5mM EGTA) was layered on top of 8ml of Percoll medium
[225mM mannitol, 25mM Hepes (pH 7.4), 1mM EGTA, and
30% Percoll (v/v)] in a 10-ml polycarbonate ultracentrifuge
tube and centrifuged for 30min at 95.000 × g. A dense band
containing purified mitochondria, recovered approximately 3/4
down the tube, was removed, diluted with isolation medium,
washed twice by centrifugation at 6.300× g for 10min to remove
the Percoll, and finally resuspended in isolation medium. MAM,
removed from the Percoll gradient as a diffuse white band located
above the mitochondria, were diluted in isolation medium and
centrifuged at 6.300 × g for 10min. The supernatant containing
MAM was centrifuged at 100.000 × g for 1 h in a Beckman
70 Ti rotor, and the resulting pellet was resuspended in the
homogenization buffer.
The quality of the preparation was checked by western blot
analysis using different markers for the fractions obtained: IP3R
was used as marker of ER, tubulin as marker of cytoplasm and
the Voltage Dependent Anion Channel (VDAC) as marker for
mitochondria.
Immunoblot and Immunocytochemistry Analysis
Thirty micrograms of proteins were used for each sample
in denaturing sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE). Western blot analysis was
performed as described (Tiranti et al., 1999), using the
ECL-chemiluminescence kit (Amersham) according to the
manufacturer’s protocol.
Antibodies
For immunodetection of the C19orf12 protein, western-blot
analysis with a antisera specific for C19orf12 (1:1000) was
performed, as previously described (Hartig et al., 2012). An
anti-Myc monoclonal antibody (OriGene) was used at a
final concentration of 1µg/ml. An anti-NADH dehydrogenase
ubiquinone 1 alpha subcomplex subunit 9 (NDUFA9) antibody
was used (Invitrogen) at final concentration of 0.5µg/ml. A
mouse monoclonal anti-b-TUBULIN antibody was used at a final
concentration of 1µg/ml (Sigma-Aldrich). An anti-ethylmalonic
encephalopathy 1 rabbit polyclonal antibody was used at 1:2000
dilution (Tiranti et al., 2004). An anti-VDAC (1:3000) from
Abcam (Cambridge, UK). An anti-IP3R3 (1:300) from BD
Biosciences (San Jose, CA, USA). Secondary anti-rabbit and anti-
mouse antibodies were used at 1:7000 and 1:5000 dilutions,
respectively.
Automated Nuclei Count Analysis
Fibroblasts were seeded at 50,000 cells on a 25-mm coverslip,
allowed to grow for 48 h and then treated with H2O2. Coverslips
were stained with 10µM Hoechst, placed in an incubation
chamber with a controlled temperature and mounted on an
Axiovert 200M microscope equipped with a motorized stage.
Nuclei were acquired with a 10x Fluar objective (Zeiss) and a
CoolSnap HQCCD camera. Twenty random fields were acquired
with the random stage scan tools in MetaMorph and analyzed
with the nuclei count application.
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Autophagy Induction and Inhibition
Twenty four hours after seeding, cells were extensively washed
with PBS to remove any traces of the previous medium and then
exposed to EBSS (Sigma-Aldrich) or to NH4Cl 2mM for 3 h at
37◦C and with controlled humidity and CO2.
Autophagosomes Count
HeLa cells were seeded as previously stated then transfected with
a mix of LC3-EGFP cDNA in pcDNA3 and C19orf12-mKate2 or
pmKate2 using the transfection procedure previously described.
Thirty six hours after transfection cells were stained with Hoechst
1µM then imaged with an Axiovert 200Mmicroscope equipped
with a motorized stage and a CoolSnap HQ CCD camera. Ten
random fields were acquired using a Zeiss 40X water immersion
lens (N.A. 1.2). Images were then processed and autophagosomes
counted using a custom made pipeline for the open source
software Cell Profiler (Carpenter et al., 2006).
Aequorin Measurements
Cells grown on 13mm round glass coverslips at 50% confluence
were transfected with the mitochondria targeted aequorin.
All aequorin measurements were carried out in 1mM
Ca2+ KRB buffer (NaCl 135mM, KCl 5mM, MgSO4 1mM,
K2HPO40.4mM, Glucose 5.5mM, HEPES 20mM). Agonists and
other drugs were added to the same medium, as specified in
the figure legends. Experiments were stopped by lysing the cells
with 100µM digitonin in hypotonic Ca2+-rich solution (10mM
CaCl2 in H2O), thus discharging the remaining aequorin pool.
The light signal was collected and calibrated into [Ca2+] values,
as previously described (Bonora et al., 2013).
Molecular Modeling
The prediction of the transmembrane region has been carried
out by MEMSAT3 (Jones, 2007) and its secondary structure
propensity by McGuffin et al. (2000). The sequence of
the predicted soluble regions of C19orf12 (C19orf11−40and
C19orf1280−151) was used as a target sequence for homology
modeling. The model was obtained by Modeller version 9.11
(Eswar et al., 2006) using the structure of its closer homolog,
i.e., the Mg2+ transporter belonging to the MgtE class isolated
from Thermus thermophilus (PDB entry 2yvy, chain A, residues
31–134, resolution 2.30 Å, (Hattori et al., 2007) as a template.
C19orf12 shares 26% of sequence identity and 56% of sequence
similarity with the template. The guide alignment for the
prediction has been derived by HHPred (Söding et al., 2005)
and then manually corrected to improve the match between the
secondary structural elements of the template and the predicted
secondary structural elements of the target, as well as to improve
local sequence identity (Supplementary Figure 3). Model quality
has been evaluated by AIDE program (Mereghetti et al., 2008).
Results
Wild-Type and Mutants C19orf12 Sub-Cellular
Localization in Native Conditions
Prediction based on the amino acid sequence of human
C19orf12 and fractionation experiments indicated that it was a
mitochondrial membrane-bound 17-kDa protein (Hartig et al.,
2012).
To demonstrate sub-cellular localization we performed
Western-blot analysis on HeLa cells transfected with MYC-
tagged C19orf12 cDNA. Western-blot analysis showed that wild-
type C19orf12 gene product was present into the mitochondrial
membranes but also in the lysate and cytosol (Figure 1A).
Because of its putative function in lipid metabolism (Hartig
et al., 2012) we reasoned that the protein could have additional
sub-cellular localizations. To demonstrate this we isolated
different HEK293 fractions containing: crudemitochondria, pure
mitochondria, membrane associated mitochondria (MAM), and
ER.
Western-blot analysis of the different sub-cellular fractions
using a specific C19orf12 antibody, indicated that the wild-type
protein was present in both mitochondria and ER (Figure 1B)
under naïve condition. Moreover, a small fraction of the protein
was also detected in the MAM, which represent physical
association between mitochondria and endoplasmic reticulum
important for the transport of phospholipids (Patergnani et al.,
2011; Marchi et al., 2014).
Antibodies specific to proteins known to be located into
different sub-cellular compartments were used as controls. In
particular, Inositol 3 Phosphate receptor 3 (IP3R3) was used as
marker of ER, tubulin as marker of cytoplasm and the VDAC as
marker for mitochondria.
To understand the localization of the mutant C19orf12
proteins, we performed Western-blot analysis on HeLa
cells transfected with C19orf12 versions, carrying the point
mutations G58S and Q96P. The level of overexpression of
Myc-tagged versions in relation to endogenous C19orf12 was
evaluated by Real-time PCR and an histogram is reported in
Supplementary Figure 1.
In the presence of G58S mutation, located in the predicted
transmembrane domain, the mutant protein is also found in the
mitochondrial matrix (Figure 1C). On the contrary the Q96P
mutation has no effect on the localization of the protein, which
is mainly present in the mitochondrial membranes (Figure 1D)
as observed for the wild-type protein.
Wild-Type and Mutants C19orf12 Live Imaging
Analysis
To further corroborate the data obtained by Western-blot we
performed experiments of live imaging in cells transfected with
mkate2-tagged wild-type C19orf12, G58S, and Q96P mutant
versions.
Cells transfected with the wild-type displayed a network-like
intracellular staining with small tubular structures resembling
the ER tubules and thicker structures similar to mitochondria
(Figure 2). This localization was confirmed by confocal
colocalization microscopy. mKate2 signal in fact display
significant colocalization with the ER marker GFP–Sec61-β
and also with the mitochondrial marker mitotracker Deep Red
(as indicated by the high values of Pearson’s and Mander’s
coefficients representing respectively the correlation between the
two signals and the proportion of mKate2 signal overlapping
with mitochondria or ER).
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FIGURE 1 | Subcellular localization of wild-type and mutant
C19orf12. HeLa cells transfected with wild-type C19orf12MYC construct
(A) and mutant versions G58S−C19orf12MYC construct (C), and
Q96P−C19orf12MYC construct (D), were harvested to obtain
mitochondria and other fractions. Equal amount of proteins (30µg) from
each fraction were resolved by SDS-PAGE and immunostained with
antibodies against C19orf12 and MYC to specifically detect protein
sub-localization. Anti-NDUFA9, TUBULIN, and ETHE1 were used as
control of mitochondrial membranes, cytosol fractions and mitochondrial
matrix respectively. (B) Detection of naïve C19orf12 (red arrow) by
immunoblotting in HEK 293 cells fractionation. The lower band is
probably an unspecific signal. Mitochondria c, crude mitochondria;
Mitochondria p, pure mitochondria; ER, endoplasmic reticulum; MAM,
mitochondria-associated membrane. IS, Intermembrane space. IV, In vitro
translation product. Anti-IP3R, VDAC, and Sigma-1R were used as ER,
mitochondria and MAM markers respectively.
TheG58S presented with a predominant cytosolic distribution
that generates asymmetric behaviors in the colocalization indexes
(Figure 2). Differently from what observed with the wild-type
chimera, the Q96P displayed a vesicles pattern with a partial
co-localization vs. the mitochondrial and ER compartments (as
displayed by a reduction in the Pearson’s coefficients) (Figure 2).
Overall, the colocalization experiment confirms the data obtained
by western-blot analysis (Figure 1) on different sub-cellular
fractions.
Response to Oxidative Stress
To test response to oxidative stress we treated cells transfected
with wild-type and mutant C19orf12 GFP-tagged versions,
with 500µM H2O2 for 80min and we followed the cellular
localization of the protein by live imaging during time. After
30min from H2O2 addition, we observed that the wild-type
changed its localization pattern from reticular to cytosolic and
generated bright aggregates in proximity to the mitochondrial
network (Figure 3). In addition, after persistent exposure to
oxidative stress, it generates bright aggregates that partially
colocalize with mitochondrial network (Figure 3B).
On the contrary, both mutant G58S (Figure 4) and Q96P
(Figure 5) versions display minor redistribution as indicated
by the variation in the Pearson’s coefficient. Only the mutant
Q96P displayed a significant increase in Pearson’s coefficient
that remains in any case lower then 0.5, usually considered as
threshold for a relevant correlation (Bolte and Cordelières, 2006)
suggesting that this mutant increases its cytosolic distribution
without affecting dramatically its mitochondrial localization.
We also tested apoptotic cell death after H2O2 treatment and
we observed that fibroblasts derived from the patient carrying the
G58S change were more sensitive to treatment and showed a high
percentage of cells death as compared to two control fibroblasts
(Figure 6). We could not test the Q96P mutation since patient’
fibroblast were not available.
Analysis of Mitochondrial Ca2+ Homeostasis
In order to measure mitochondrial Ca2+ handling (Marchi et al.,
2014) in controls and patient-derived fibroblasts we carried
out mitochondrial [Ca2+] ([Ca2+]m) measurements using the
mitochondrial-targeted aequorin probe (Bonora et al., 2013). To
this end we stimulated the cells with an agonist, ATP, acting
on receptors coupled, through Gq proteins, to the production
of inositol 1,4,5 trisphosphate (IP3) and in turn to the opening
of the IP3 receptor. Both in control and cells harboring
the G58S mutation, ATP stimulation caused a rapid rise in
[Ca2+]m followed by a gradually declining sustained plateau.
In patient-derived fibroblasts, the [Ca2+]m increases evoked by
stimulation with ATP were significantly greater than in controls
(Figure 7).
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FIGURE 2 | Intracellular localization of wild-type and mutant
C19orf12-mKate2 fusion protein. Representative HeLa cells
overexpressing wild-type C19orf12-mKate2 (red signal) or mutant variants
G58S and Q96P. C19orf12-mKate2 colocalization with mitochondria (blue
signal) or ER (green signal) is represented by two colors image merging
of kate2 vs. mitochondrial (magenta signal) or vs. ER (yellow signal). For
each merging the relative colocalization scatterplot is inserted as inset on
bottom right corner. Analysis of colocalization is represented by Pearson’s
coefficient (indicating the correlation between mKate2 and mitochondria or
ER signals) and by the Mander’s Red coefficient (representing the
proportion of mKate2 signal overlapping with mitochondria or ER). Bars:
S.E.M., *p < 0.05.
Evaluation of Autophagy
In order to understand the nature of the aggregates formed
by the wild-type protein, surrounding mitochondria, we
performed colocalization study using the specific autophagy
marker LC3. Confocal live imaging of LC3 vesicles and
C19orf12 displayed that the C19orf12 redistribution induced
by oxidative stress inversely correlated. Indeed while H2O2
induced aggregates formation it also reduces the amount
of LC3 vescicles (Supplementary Figure 2A). The amount of
colocalized dots increased about 50% in response to H2O2
exposure (Supplementary Figure 2Aiv). Overall 3D confocal
microscopy display that only a minor proportion of LC3-
EGFP puncta co-localize with C19orf12-mKate2 aggregates after
H2O2 exposure (Supplementary Figures 2B). Nonetheless, the
effect of C19orf12 on autophagy was evaluated. Coexpression
of the autophagic reporter LC3-EGFP and of C19orf12-mKate2
displays a higher amount of EGFP punctae (autophagosomes)
compared to cells expressing the autophagic marker with the
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FIGURE 3 | Redistribution of C19orf12 during oxidative stress. (Ai)
Representative images of HeLa cells overexpressing the C19orf12-EGFP
fusion protein and the mitochondrial marker mtDsRED before (upper panel),
and after (lower panel) exposure to H2O2 500µM. (ii) Quantitative analysis of
EGFP and DsRED signal before and after oxidative stress (cross, average;
line, median; box, 25 and 75 percentile; bars, max and min value, n = 8,
*p > 0.05). (Bi) Representative distribution of C19orf12-EGFP fusion protein
in HeLa cells displayed with low contrast and the mitochondrial marker
mtDsRED before (left panel) and after (right panel) exposure to H2O2
500µM. (ii) Quantitative analysis of C19orf12-EGFP aggregates colocalizing
with the mtDsRED signal during challenging with H2O2 500µM (continuous
line, mean; dashed lines, S.E.M., n = 8).
pmKate2 empty vector (Figure 8A). This data was corroborated
by analysis of endogenous LC3 marker. Overexpression of the
EGFP tagged wild type C19orf12 induce the conversion of
the autophagic marker LC3 heavy form (LC3I) to the light
form (LC3II) compared to cells transfected with the empty
EGFP vector, indicating the elevation of basal autophagic levels
(Figure 8B). In both assays the LC3 conversion was further
stimulated when inducing autophagy by exposing cells to EBSS
medium. The promoted conversion of LC3 induced by C19orf12-
EGFP overexpression did not appear as a blocked autophagic
flux. In fact, overexpression of this plasmid was sufficient to
induce a reduction of the autophagic marker p62. This protein
is usually required for autophagosome formation and its levels
are expected to decrease during autophagy due to degradation of
autophagosome content (Klionsky et al., 2012). Indeed treatment
with NH4Cl lead to impaired acidification of autophagosomal
content and inhibition of autophagosome degradation, with
concomitant LC3 conversion and p62 accumulation (Figure 8C).
Interestingly, H2O2 treatment inhibits the observed effect
on autophagic levels (Figure 9) but caused the relocalization
of C19orf12 (Figure 3). In support of this observation, the
overexpression of the vectors carrying the mutant forms G58S
and Q96P was unable to induce LC3 conversion suggesting
a localization dependent role for C19orf12 in regulation of
autophagy (Figure 9).
In Silico Analyses
We carried out both secondary structure prediction of the
full C19orf12 sequence and modeling of the predicted soluble
region (C19orf121−40/81−151) to both understand functional
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FIGURE 4 | Redistribution of C19orf12 G58S mutant during
oxidative stress. Representative HeLa cells overexpressing the
C19orf12 G58S-EGFP fusion protein and the mitochondrial marker
mtDsRED before (upper panel) and after (lower panel) exposure to
H2O2 500µM. Quantitative analysis of EGFP and DsRED signal
before and after oxidative stress (cross, average; line, median; box,
25 and 75 percentile; bars, max and min value, n = 8) is shown on
the right.
FIGURE 5 | Redistribution of C19orf12 Q96P mutant during
oxidative stress. Representative HeLa cells overexpressing the
C19orf12 Q96P-EGFP fusion protein and the mitochondrial marker
mtDsRED before (upper panel) and after (lower panel) exposure to
H2O2 500µM. Quantitative analysis of EGFP and DsRed signal before
and after oxidative stress (cross, average; line, median; box, 25 and
75 percentile; bars, max and min value, n = 8, *, p > 0.05) is shown
on the right.
and structural properties of the wild-type protein and the
effects of the mutations. C19orf12 was predicted to contains
two α-helices located in the trans-membrane (TM) region
(Supplementary Figure 3) rich in glycine residues, of which
several have been found mutated in MPAN patients: G58S
(Panteghini et al., 2012), G53R, G65E, G69R, (Landouré
et al., 2013) C19orf12 contains in the transmembrane helix
glycine zipper motifs, (GxxxGxxxG) (Kruer et al., 2014).
The most significant glycine zipper patterns in proteins
that have been reported so far are (G,A,S)XXXGXXXG
and GXXXGXXX(G,S,T) (Kim et al., 2005). The first
motif (AXXXGXXXG) corresponding to the sequence
50AFVGGLVGG58 where both G53R and G58S mutations
occur is located in close proximity to the first TM α-helix. The
second motif 61GLAVGGAVGGLLG73 is longer and contains
two of those repeats, with the mutations G65E and G69R. The
N- and C-terminal residues (C19orf121−41/77−151) are predicted
to rearrange in a soluble three-dimensional (3D) domain
homologous to the N-regulatory domain of the bacterial Mg2+
transporters of the MgtE (Maguire, 2006; Payandeh et al., 2013).
In the MgtE transporters, this domain forms a right-handed
superhelical structure that includes 10 helices per two turns.
Our model does not provide a reliable prediction for the first
14 amino acids of C19orf12, which would correspond to the
first two helices of the right-handed superhelical motif due to
poor sequence similarity with known structures of MgtE-like
transporter. The rest of the domain is well conserved with respect
to the bacterial homologs and in this region the Q96P is located
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in the middle of one of the α helices (corresponding to the α6
of the bacterial N-domain) and well packed within the domain
(Figure 10). It is a mutation from a polar residue to a proline,
which is a well-known helix-breaker. FoldX (Schymkowitz et al.,
2005) energy was used to estimate the free-energy changes upon
Q96P mutation. In particular, the changes in protein stability
upon the mutation were estimated as the difference (11G)
between the free energies of unfolding (1G) of the mutant
and the wild-type variant. 11G values above 1.6 kcal/mol are
expected to significantly affect stability because they correspond
to twice the standard deviation of FoldX (Schymkowitz et al.,
2005) Q96P mutation is predicted to impair protein stability
of 5.4 ± 0.3 kcal/mol, (Guerois et al., 2002) suggesting a loss
of protein stability upon this mutation In the model structure,
Gln96 is predicted to be involved in side-chain hydrogen bonds,
as the one with Ser124, located in the loop than connect helices
α8 and α9 (Figure 10). The structural rearrangement caused by
Q96Pmutationmight influence the network of polar interactions
mediated by Gln95.
FIGURE 6 | Fibroblasts with C19orf12 mutation are more sensitive to
cell death. Human fibroblasts were treated with Hydrogen Peroxide (2mM
H2O2 for 5 h). Apoptosis was evaluated using an automated nuclei count
analysis. Numbers above bars indicate the percentage of cell death in the
presence of H2O2 as compared to the corresponding untreated sample.
Discussion
C19orf12 was reported to code for a mitochondrial membrane
protein probably involved in lipid metabolism (Hartig et al.,
2012). We here demonstrated that C19orf12 protein is not
only present in mitochondria but also in ER and MAM. These
are zones of close contact between ER and mitochondria,
which support communication between the two organelles
as concerning lipid transfer and Ca2+ ions exchange. This
activity regulates several processes including: ER chaperone-
assisted folding of newly synthesized proteins, modulation
of mitochondria-localized dehydrogenases involved in
ATP-producing Krebs cycle reactions, activation of Calcium-
dependent enzymes that execute cell death programs (Berridge,
2002). We observed that the G58S mutant protein was also
present into the mitochondrial matrix and we reasoned whether
this different sub-cellular localization could also affect its
functionality. The C19orf12 protein belongs to the clan of
glycine zipper containing membrane domains (Kim et al.,
2005). The majority of C19orf12 mutations are clustered in
a functional region, which is crucial for this superfamily of
proteins and is characterized, in the TM regions, by long and
repeated glycine-zipper motifs, generally GxxxGxxxG. This
is a common motif in several multimeric known membrane
channel structures, where the glycine faces are in direct contacts
(Kim et al., 2005). Notably, this pattern is statistically over-
represented in membrane proteins in general (Kim et al.,
2005). It has been indeed proposed to be the driving force for
right-handed packing against a neighboring helix. It has also
been suggested to play a crucial role in gating mechanisms (Kim
et al., 2005). The glycine zipper motifs of C19orf12 suggest
that they are involved in the interaction between the two TM
helices of this protein, even if we cannot rule out also a putative
involvement in homo-dimerization. Mutations of the glycines
of the glycine-zipper motif to charged or polar residues, as
observed in the mutant C19orf12 patients, were likely to impair
the correct localization of the protein in the membrane. These
bioinformatics predictions fully agreed with the experimental
FIGURE 7 | Fibroblasts with C19orf12 mutation displayed increased
Ca2+ mobilization. (A) Mitochondrial Ca2+ responses to agonist
stimulation (100µM ATP) measured in human fibroblasts. Graphs show
quantification of mitochondrial Ca2+ from three independent experiments.
(B) Representative traces of Ca2+ responses. CTR [Ca2+]m peak 17. 0 ±
1.96µM; G58S [Ca2+]m peak 43. 4 ± 8.09µM.
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FIGURE 8 | Analysis of autophagy during C19orf12 wild-type
overexpression. Representative images of HeLa cells overexpressing
C19orf12-mKate2 or empty pmKate2 simultaneously with the autophagic
marker LC3-EGFP (A) in basal condition or after exposure to EBSS. In
the lower panel quantification of autophagosome counts is displayed
(cross, average; line, median; box, 25 and 75 percentile; bars, max and
min value, n = 8, ***p > 0.005, ****p > 0.001). (B) Representative western
blot analysis of autophagic markers LC3 and p62 in HeLa cells
overexpressing C19orf12-EGFP or EGFP empty vector as control in basal
condition or after exposure to EBSS (bars, S.E.M.; n = 4; *p > 0.05). (C)
Representative western blot analysis of autophagic marker LC3 and p62
in HeLa cells overexpressing C19orf12-EGFP or EGFP empty vector as
control in basal condition or after exposure to NH4Cl 2mM (bars, S.E.M.;
n = 4; *p > 0.05).
data obtained by western-blot investigation. Indeed, we observed
a prevalent cytosolic localization of the mutant G58S protein,
while the fraction present in mitochondria was also found in the
matrix, indicating that the protein was not tightly bound to the
membrane.
Interestingly, glycine zipper motifs have been found in Ap and
PrP, which are associated with Alzheimer’s and prion diseases.
A neuropathological hallmark of both Alzheimer’s disease and
spongiform encephalopathies includes the formation of deposits
in the brain such as amyloid plaques, glial responses and
neurofibrillary tangle (Jeffrey, 2013). It is important to notice
that histopathological examination of the brain from a single
MPAN patient also revealed the presence of Lewy bodies, tangles,
spheroids, and tau pathology (Hartig et al., 2012), suggesting
a possible common pathological role for the motif in these
neurodegenerative disorders.
We predicted that C19orf12 soluble domain is homologous to
the N-terminal regulatory domain of bacterial MgtE transporters.
The comparison of the Mg2+-free and –bound structures of a
MgtE transporter (Hattori et al., 2007) and NMR experiments
(Imai et al., 2012) showed a rearrangement of the N-domain
upon Mg2+-interaction. Moreover, MgtE variants lacking the
N-terminal subdomains showed a reduced Mg2+-dependent
inhibition and an increased open probability, implicating this
subdomain in MgtE function and regulation (Hattori et al.,
2009), acting as a sensor of Mg2+ concentration. In eukaryotic
organisms, MgtE-like genes belong to the SCL41 family and
their precise role is unknown (Fleig et al., 2013; Schweigel-
Röntgen and Kolisek, 2014). Interestingly, the N-terminal
regulatory domain of bacterial MgtE is missing in SLC41-A1,
thus implying that the eukaryotic transporters evolved different
mechanisms of regulation (Schweigel-Röntgen and Kolisek,
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FIGURE 9 | Analysis of autophagy during C19orf12-EGFP wild-type
and mutants overexpression. Representative western blot analysis of
autophagic marker LC3 in HeLa cells overexpressing C19orf12-EGFP,
C19orf12 G58S-EGFP, C19orf12 Q96P-EGFP, or EGFP empty vector as
control (left panel). Densitometry of light LC3 chain (LC3II) bands normalized
on heavy LC3 chain (LC3I) bands is shown (right panel). Analysis was
performed in basal condition or after stimulation with 500µM H2O2 for
80min (bars, S.E.M.; n = 4, *p > 0.05).
FIGURE 10 | Secondary and tertiary structure of C19orf12. Left
panel: The prediction of transmembrane regions carried out with
MEMSAT is illustrated and the residues of the transmembrane region,
which are predicted in helical structures by PSI-Pred are highlighted in
green. Right panel: The three-dimensional (3D) model of the C19orf12
domain homologous to the MgtE N-domain is shown in cartoon. The
mutation site Gln96 and the residues Ser214 are shown as sticks and
spheres. The protein is shown with shade of colors from blue to red,
from the N- to the C-terminal extremity, respectively. The dots and the
arrows illustrate the regions that are expected to connect the domain to
the membrane. Gly58 is not reported since a reliable 3D model is not
available for the transmembrane domain.
2014). The homology of the soluble portion of C19orf12 with
this bacterial subdomain, and its localization in membrane,
would support a function for C19orf12 as a regulatory
domain of eukaryotic MgtE-like proteins, different from
SLC41-A1.
In silico investigation of the Q96P predicted for this mutation
to cause loss of side-chain mediated hydrogen bonds and to affect
the correct architecture of a central α-helix in the 3D structure
of the C19orf12 soluble domain homologous to the N-terminal
regulatory domain of bacterial MgtE transporters. This suggests
a possible role of the α domain in the interaction and regulation
of C19orf12 protein with human MgtE-like transporters, acting
as a regulatory protein.
Interestingly, deficiency of systemic and intracellular
magnesium (Mg) has long been suspected to contribute to
the development and progression of Parkinson’s and other
neurodegenerative diseases, although the molecular mechanism
is still unknown (Kolisek et al., 2013).
To gain insight into the pathogenic role of C19orf12 inMPAN
we performed in vitro investigations by challenging the cells
with stressful conditions and by evaluating the response of the
wild-type and mutant C19orf12 proteins.
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We proved that the wild-type C19orf12 protein was able
to respond to oxidative stress by enriching its cytoplasmic
localization and forming aggregates, which partially co-localized
with mitochondria. On the contrary, both C19orf12 mutant
proteins were insensitive to oxidative stress and did not form
aggregates. In light of the recent observation, that the ER–
mitochondria contact sites are important in autophagosome
formation (Hamasaki et al., 2013) we proposed a putative
role for C19orf12, in control of autophagy. In support of
this hypothesis we observed that overexpression of wild-type
C19orf12 resulted in conversion of autophagic marker LC3
and reduction of levels of p62. On the contrary, induction
of delocalization by oxidative stress results in reduction of
autophagy LC3 conversion. Interestingly, the overexpression of
mutants, unable to properly gain its intracellular localization, fails
to promote autophagy induction and levels of basal autophagy
remain unchanged during exposure to oxidative stress.
Live imaging suggested that delocalization of C19orf12
appears related to existence of LC3-vescicles. Indeed the
progressive accumulation of C19orf12 in cytoplasm and
its accumulations in aggregates were concomitant with the
reduction in number of LC3-EGFP vesicles. Furthermore, the
amount LC3-EGFP vescicles co-localizing with C19orf12 was
extremely low. Since it was reported that the marker LC3-
EGFP could produce non-autophagosome related aggregates
(Kuma et al., 2007), also C19orf12 aggregates co-localizing
with LC3 puncta have dimension larger then 1.5µm (average
feret 1.98µm, SEM 0.17, n = 9) suggesting that these were
not autophagosomes. These results would therefore suggest
that the C19orf12 is contemporary able to exert an inhibitory
effect on apoptosis induction and a stimulatory effect on
autophagy. The loss of autophagy induction observed after
mutants overexpression and the increased sensitivity to apoptosis
in patients-derived fibroblasts carrying mis-localized mutants,
suggests that C19orf12 can induce protective autophagy at the
expense of apoptosis and that this effect could be dependent on
its intracellular localization.
These results suggest that C19orf12 could be involved in
removal of dysfunctional mitochondria by selective autophagy
(in a fashion independent on aggregates formation). Considering
that MPAN disease mainly affects the brain, it is well possible that
neurons carrying C19orf12 mutations, could accumulate altered
mitochondria which can’t be removed because of the presence
of C19orf12 mutations, and could degenerate and/or eventually
die. Nonetheless the present results about the role of C19orf12
in regulation of autophagy will require more detailed studies in
future.
Finally, we also observed high levels of mitochondrial
Ca2+ in fibroblasts derived from patients as compared to
control, suggesting that the mutations altering the intracellular
distribution of C19orf12 is detrimental for proper mitochondrial
function and Ca2+ homeostasis. As a consequence, patient-
derived fibroblasts were more sensitive to Ca2+ dependent
apoptotic stimuli like H2O2 induced death as compared to
control fibroblasts.
We here demonstrated that C19orf12 protein involved in
NBIA is located in mitochondria and also present in the ER
as previously reported (Landouré et al., 2013), and MAM.
Moreover, we proposed a role for this protein as a sensor of
mitochondrial damage. We also demonstrated that patients-
derived fibroblasts accumulated high levels of mitochondrial
Ca2+ and were more prone to oxidative stress induced apoptosis.
Altogether these data shed new light in the field of NBIA focusing
the attention on the role of mitochondria-ER connection in
the transfer of essential lipids, in calcium metabolism and in
autophagosome formation (Hamasaki et al., 2013), which are
fundamental for the maintenance of cellular homeostasis and
for determination of cell fate under pathological condition.
A role of MAM has been recently proposed in another
neurodegenerative disorder that is Alzheimer’s disease (Schon
and Area-Gomez, 2010) with the demonstration that presenilin
1 and 2 are predominantly located into these specialized
structures. It is well possible that proteins such as presenilin
1 and 2, and C19orf12, can shuttle between different sub-
cellular compartments depending on the cells status. Moreover,
molecular homology modeling suggested a putative role for
C19orf12 in regulation of magnesium transport. Magnesium
homeostasis is crucial for learning andmemory and has a positive
effect on synaptic plasticity and density (Barbagallo et al., 2009;
Slutsky et al., 2010). Moreover, magnesium and calcium work
together to modulate ion channels, which open in response to
nerve impulses triggering neurotransmitter release (Slutsky et al.,
2004; Bardgett et al., 2005). These observations are particularly
relevant in the context of a neurodegenerative disease such
as NBIA, but dedicated experiments are required to further
demonstrate this hypothesis.
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Supplementary Figure 1 | Real-time PCR to evaluate expression level of
C19orf12-MYC. Expression level of overexpressed C19orf12-MYC versions
(wild-type, G58S, Q96P, respectively) evaluated as fold-change in comparison to
endogenous C19orf12.
Supplementary Figure 2 | (Ai) Representative behavior of C19orf12-mKate2
aggregates and LC3-EGFP before (left panel) and after (right panel) exposure to
H2O2 500µM. Quantitative analysis of channel independent spot counts:
LC3-EGFP vescicles (ii), mkate2 aggregates (iii), and colocalized spot (iv) during
challenging with H2O2 500µM (continuous line: mean, dashed lines: S.E.M.,
n = 8). (B) Representative 3D images of autophagic vesicles in presence of H2O2
500µM. (i) LC3-EGFP (green), (ii) C19orf12-mKate aggregates (red), and
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(iii) colocalization signal (yellow). Multiple orthogonal view of the merged signal are
displayed and marked by sequential numbering. (iv) Percentage of
C19orf12-mKate2 aggregates colocalizing with LC3 vescicles (v) LC3 puncta
co-localizing with mKate2 aggregates (cross, average; line, median; box, 25 and
75 percentile; bars, max and min value, n = 12).
Supplementary Figure 3 | Guide alignment for homology modeling. The
sequence alignment between the target (C19orf12) and the template (PDB entry
2yvy, chain A) is shown as derived by the HHPred multiple sequence alignment
upon manual correction (see Materials and Methods). “∗” and “.” indicates
identical and similar residues, respectively.
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